With the PYCOA, there are about 520 million shares on offer, so a $4 share price would be $2 billion. That's a ludicrous valuation and it's unprofessional that anyone associated with the company suggested such a thing.
There'll be more dilution before we're done - any pharma taking an equity stake isn't going to pay through the nose for it - and getting back to a $30 million valuation would be a good first step.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.21 |
Change
-0.030(2.42%) |
Mkt cap ! $705.7M | |||
| Open | High | Low | Value | Volume |
| $1.24 | $1.26 | $1.21 | $627.7K | 506.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4985 | $1.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.26 | 4115 | 1 |
View Market Depth
| Last trade - 16.10pm 01/08/2025 (20 minute delay) ? |
| PYC (ASX) Chart |